Public Health Genetics Overview

Principles

Definition

Public health genetics is an interdisciplinary field that applies genetic and genomic information and technologies to understand the interplay of genes, environment, and social factors on health and disease within populations. This field aims to inform public health interventions, improve population health outcomes, reduce health disparities related to genetic factors, and address the ethical, legal, and social implications of genetic advances.

Ontological type

Ethical and Legal Issues

Core Methods

Population Screening

Key developments

Key Figures

Foundations of Genome Mapping era

Neil Risch[1], associated with Rockefeller University[2] and Harvard University[3] during this era, emerged as a leading figure in population genetics. His key contribution, as expressed in The Future of Genetic Studies of Complex Human Diseases[4], was to articulate a forward-looking agenda for studying complex diseases through genome-wide and polygenic approaches, anchoring the era's shift toward population-based study designs. This agenda supported the development of large-scale gene catalogs and genome resources and helped justify integrating genetic findings into population health research. Together, these efforts framed governance and methodological innovations essential to translating genetic knowledge into public health policy.

Causal Genetic Epidemiology era

George Davey Smith [1] is a pivotal figure in public health genetics during the causal genetic epidemiology era, with affiliations at Harvard University [2] and the Peninsula College of Medicine and Dentistry [3]. His 2003 paper 'Mendelian randomization' [4] demonstrates how genetic instruments can strengthen causal inference in observational health research, a foundational contribution that helped establish MR as a central methodological tool of this era. George Davey Smith [1] helped solidify Mendelian randomization [4] as a routine tool for causal inference in observational health research during this era. George Davey Smith [1] further shaped the field by promoting rigorous design, replication, bias control, and thoughtful governance around causal genetics.

Population-scale Genomic Integration era

Paul Elliott [1] is a leading figure in population health genetics associated with Harvard University [3] and the Massachusetts Institute of Technology [4] in this era. His key contribution, illustrated by the UK Biobank [5], was championing an open access resource that enables large-scale, multi-ethnic genomic epidemiology and systematic discovery of disease causes. Christopher J. O’Donnell [2] is a leading figure associated with Harvard University [3] and the Massachusetts Institute of Technology [4] in this era. A core contribution is the Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program [6], which underscores cross-ancestry lipid genetics and informs risk stratification in population-scale public health.